ALNY Alnylam Pharmaceuticals, Inc.

Healthcare

$295.50-0.66%ClosedMarket Cap: $39.45B

As of 2026-05-26

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$10.67	$7.33B	15
Sun Dec 31	$13.19	$8.71B	16
Mon Dec 31	$15.81	$10.16B	14
Tue Dec 31	$19.43	$11.74B	14